UPC claims power to stop patentees escaping validity decisions via withdrawal
The court has largely dismissed a preliminary objection filed by Novo Nordisk against three unusual requests brought by Sandoz alongside its ordinary revocation claim (case ID: UPC_CFI_2221/2026).